HSV-2 gC Antibody (H1196): sc-69801

HSV-2 gC Antibody (H1196) is a mouse monoclonal IgG2a antibody that detects HSV-2 gC protein by western blotting (WB) and immunofluorescence (IF). Anti-HSV-2 gC antibody (H1196) is available as non-conjugated format, providing researchers with a reliable tool for studying this critical viral protein. Herpes simplex virus 2 (HSV-2) is known for causing genital herpes, a condition that leads to significant discomfort and impacts sexual health. HSV-2 gC protein plays a vital role in viral immune evasion by binding to complement component C3b, effectively inhibiting complement-mediated neutralization and allowing viral persistence in the host. This immune evasion enables viral survival and replication, particularly during asymptomatic periods when HSV-2 remains dormant in nerve cells. Understanding HSV-2 gC function and immune system interactions can provide insights into potential therapeutic targets and strategies for managing HSV infections.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

HSV-2 gC Antibody (H1196) References:

1. Monoclonal antibodies suitable for type-specific identification of herpes simplex viruses by a rapid culture assay.  |  Bystrická, M., et al. 1999. Acta Virol. 43: 399-402. PMID: 10825932
2. Herpes simplex virus type 1-encoded glycoprotein C enhances coagulation factor VIIa activity on the virus.  |  Sutherland, MR., et al. 2004. Thromb Haemost. 92: 947-55. PMID: 15543320
3. Efficient replication by herpes simplex virus type 1 involves activation of the IkappaB kinase-IkappaB-p65 pathway.  |  Gregory, D., et al. 2004. J Virol. 78: 13582-90. PMID: 15564469
4. Production of herpes B virus recombinant glycoproteins and evaluation of their diagnostic potential.  |  Perelygina, L., et al. 2005. J Clin Microbiol. 43: 620-8. PMID: 15695655
5. Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains.  |  Chang, YJ., et al. 2005. Vaccine. 23: 4658-65. PMID: 15936852
6. Herpes simplex virus type 1-encoded glycoprotein C contributes to direct coagulation factor X-virus binding.  |  Livingston, JR., et al. 2006. Biochem J. 393: 529-35. PMID: 16212554
7. Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody.  |  Hook, LM., et al. 2006. J Virol. 80: 4038-46. PMID: 16571820
8. Type-common and type-specific monoclonal antibodies to herpes simplex virus types 1 and 2.  |  Bystrická, M., et al. 1991. Acta Virol. 35: 152-64. PMID: 1681713
9. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.  |  Bystrická, M., et al. 1997. Acta Virol. 41: 5-12. PMID: 9199708